Vol 19 No 3 (2013)

Vol 19 No 3 (2013)

Published June 30, 2013
https://doi.org/10.5912/jcb.v19i3

Commentary

Ananda Mohan Chakrabarty
Patenting human genes and mutations: A personal perspective
PDF
Maria Theodosiou, Arsia Amir-Aslani
The polyvalent scientist: the added value of management training
Requires Subscription or Fee PDF

Articles

Dianne Nicol, Johnathon Liddicoat, Christine Critchley
A Role for Virtual Biotechnology Companies in Drug Discovery and Development?
Requires Subscription or Fee PDF
Osne Frans Kirzner, Lorraine Marie Uhlaner
The role of specialization in mutual fund investment strategies: An exploratory study of the life sciences industry.
Requires Subscription or Fee PDF
Kola Abimbola
Culture and the Principles of Biomedical Ethics
Requires Subscription or Fee PDF
Roger Davies
The relevance and importance of business development and licensing in the biopharmaceutical industry.
PDF
Sheila Swaroop, Carol Pitzel Cruz
Patent Licensing Considerations for Biologics under the BPCIA
Requires Subscription or Fee PDF

Legal and Regulatory Updates

Joanna Brougher
Evergreening patents: The Indian Supreme Court rejects patenting of incremental improvements
Requires Subscription or Fee PDF
Gareth Williams
The life sciences industry and the changing IP landscape
Requires Subscription or Fee PDF
Ewan Grist
EU Legal & Regulatory Update
Requires Subscription or Fee PDF

Book Reviews

Steven S. Ma
Book Review: The crowdfunding revolution: How to raise venture capital using social media
Requires Subscription or Fee PDF